HF
PPCB

HRT Financial’s Propanc Biopharma PPCB Stock Holding History

HRT Financial’s Portfolio PPCB Stock Details PPCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
+10,242
New +$22.1K ﹤0.01% 3956

Other funds holding PPCB

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

HRT Financial's PPCB Position: Q2 2026 in Review

HRT Financial opened a new position in Propanc Biopharma (PPCB) in Q2 2026: 10,242 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #3956 among its holdings.

4 funds tracked by Wall St. Rank hold PPCB as of Q2 2026.

  • HRT Financial held 10,242 shares of Propanc Biopharma worth $15K as of Q2 2026.
  • Propanc Biopharma was a new HRT Financial position in Q2 2026.
  • Propanc Biopharma made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3956 holding.
  • 4 funds tracked by Wall St. Rank held Propanc Biopharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.